Accusure Insulin Syringe Recall: Needle May Detach from the Syringe
Two lots of Accusure insulin syringes have been recalled due to defective needles that can detach from the syringes during use, according to a notice posted by the FDA on Friday.
The Accusure insulin syringe recall was issued after the manufacturer, Qualtest Pharmaceuticals, Inc., received at least three reports of needles on the short needle syringes breaking off. If the needle detaches, it can slide back into the syringe during use, remain in the skin after injection or become stuck in the insulin vial.
The recall includes Accusure Insulin Syringes (1/2 cc – 31 G – Short Needle) with lot number 7CPT1 (Expiration 03/2012) – NDC 0603-7002-21. These needles were distributed between May 2007 and June 2008. The recall also includes Accusure Insulin Syringes (1/2 cc – 31 G – Short Needle) with lot number 6JCB1 (Expiration 10/2011) – NDC 0603-7001-21. The lot numbers can be found on the white paper backing on each syringe.
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
Anyone with syringes affected by the insulin syringe recall has been urged by the manufacturer to stop using them and to contact Qualitest at 1-800-444-4011 for replacements. However, product liability lawyers recommend that any consumers who have suffered a severe physical injury requiring medical treatment as a result of the defective insulin syringes, should preserve any remaining syringes in a manner to prevent further use until it has been determined whether an insulin syring recall lawsuit will be pursued.
"*" indicates required fields
More Top Stories
A Camp Lejeune non-Hodgkin's lymphoma lawsuit blames the death of a woman on her exposure to contaminated water from the military base.
Defendants want to divide the discovery process to focus on the causal links between hair relaxers and cancer.
The FDA has announced it has received 106,000 medical device reports linked to recalled Philips CPAP devices, including nearly 400 deaths.